Prof Henry Prince
Honorary (Professorial Fellow)
Department of Medicine
890 Scholarly works
11 Projects
HIGHLIGHTS
2026
Journal article
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study
DOI: 10.1016/j.tranon.2026.1028712026
Journal article
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma
DOI: 10.1182/blood.20250301902026
Journal article
Treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
DOI: 10.1111/imj.703292026
Journal article
Cutaneous Infiltration of Waldenstrom's Macroglobulinaemia—A Two-Case Series of a Diagnostically Challenging Presentation
DOI: 10.1111/ajd.700212023
Research grants (ARC, NHMRC, MRFF)
Novel Approaches to the Treatment and Monitoring of Patients With Incurable Haematological Cancers
2018
Research Grant
Immunobiology and Immunotherapy of Cancer
2009
Journal article
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure
DOI: 10.1200/JCO.2008.18.8573
RECENT SCHOLARLY WORKS
2026
Journal article
Radiotherapy dose–response of mycosis fungoides with large cell transformation
DOI: 10.1016/j.radonc.2025.1112922026
Journal article
Refractory coeliac disease or something else?
DOI: 10.1016/j.pathol.2025.08.0042026
Journal article
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
DOI: 10.1080/10428194.2025.25797212026
Journal article
Diet and risk of multiple myeloma: findings from a case-control study
DOI: 10.1017/S00071145261071562026
Journal article
Study of brentuximab vedotin combination treatment in people with early-stage Hodgkin lymphoma: a plain language summary
DOI: 10.1080/14796694.2026.26936142026
Journal article
A First-In-Human Phase 1 Study of a Novel BCMA×CD3 Bispecific T Cell Engager EMB-06 in Relapsed or Refractory Multiple Myeloma
DOI: 10.1002/ajh.70115
RECENT PROJECTS
2014
Research Grant
Victorian Epigenetics Group (Veg): A Collaboration for Personalised Epigenetic Cancer Therapy Through Pre-Clinical Evaluation, Novel Biomarker Development and Early Phase Clinical Trials of New Drugs.
2015
Research Grant
Discovery of New Treatments for Therapy-Resistant Multiple Myeloma.